Autosampler Vials Market

By Product (Crimp Top, Screw Thread, Snap Ring, Shell Vial & Others); By Capacity (Less than 1 ML, 1.1 – 1.5 ML, 1.6 ML – 2 ML, 2.1 – 2.5 ML and More than 3ML); By Application (High Performance Liquid Chromatography, Gas Chromatography & Others) By End Use Industries (Pharmaceutical & Biopharmaceuticals, Food & Beverage, Oil & Gas, Environment Testing & Others) – Global Demand Analysis & Opportunity Outlook 2018 – 2027

Buy Now
Report ID: 1515 | Published On: Feb 02, 2023
Request Free Sample Copy

Market Size and Forecast

Growing demand from end-use industries such as food, pharmaceutical, oil & gas among other industries owing to the latest technological advancements and enhancements in autosamplers is driving the growth of the market.

The global autosampler vials market with a market size of USD 806.27 million in 2018 is estimated to bring in revenues of USD 1,478.63 million by the end of 2027. The market is currently expected to register a global CAGR of 7.11% over the forecast period, i.e., 2020-2027.

Autosampler vials market Graph

Get more information on this report: Download Sample PDF

Autosampler vials market Graph
Get more information on this report: Request Sample PDF

Introductory Overview

Autosampler vials are defined as vials, made of plastic or glass, that are calibrated to be used in autosampler devices as a part of HPLC, GC or other types of devices for analyzing or purifying any sample compound. Autosamplers have the capacity to accommodate large number of sample vials in each sequence and it is very convenient to run several samples which require identical analysis.

The structural design of the products enable the prevention of any leakage in comparison to conventionally used screw cap vials and make them ideal for sample storage after processing. The vials which are usually bought together with septa and vial caps, to offer high grade performance during sample processing methods, are used for multiple injections and sample storage.

Growth Drivers

Growing Demand From End-Use Industries

The vials are essentially used within autosamplers so as to attach tightly to the specific dimensions while performing the analytical tests in laboratories’ testing programs such as impurity investigation, stability tests, quantity verification and many more. With the advent of technological advancements and enhancements in autosamplers, the demand for autosampler vials from different end-use industries such as food industry, pharmaceutical industry, oil and gas industry, etc. has increased, thereby enabling the growth of the market. Moreover, increased adoption of high-performance liquid chromatography (HPLC) and gas chromatography (GC) tests for sample purification, food and drug quality control etc. are contributing to the rise in demand for labware and consumables associated with the process.

Technological Innovations

Various product innovations are expected to positively impact the growth of autosampler market. Highly inert products made up of clear glass and amber glass are vastly preferred products, out of which, Amber glass helps in avoiding exposure to UV light thus protecting the samples of sensitive nature. 

Moreover, autosampler vials are time efficient when compared to the manual injection method. Once the samples are prepared and the analysis sequence is set, the technician is free to attend other tasks.


Factors such as spending priorities and available resources along with product and economic cycles, have a significant effect on the spending policies of the hospitals, research laboratories, pharmaceutical companies, contract research organizations, etc. Depending upon the budget allocations and the timely passage of the annual federal budget, the investments allocated for various research projects could fluctuate, which further impacts the utilization of consumable products such as autosampler vials.

Region-Wise Growth Highlights – 2020-2027

The global autosampler vials market is segmented into five major regions comprising of North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

North America held the highest market share of 34.13% in 2018 as compared to the other regions and is estimated to reach a market size of USD 513.23 million by end of forecast period. Improved laboratory infrastructure and increased funds for R&D in healthcare industry along with the growing initiatives taken by the U.S. government to upgrade the infrastructure in pharmaceutical industry, are the primary driving factors for the market growth in this region. According to OECD, in 2017, total pharmaceutical spending in the U.S. reached 1220.4 USD per capita, which covered expenditure on prescription medicines and self-medication.

The second highest growth is estimated to be witnessed by the market in Europe that is anticipated to hold around 30% share in the autosampler vials market. Europe autosampler vials market is significantly growing on account of the increasing government support in major countries of Europe such as Germany, UK, Spain, Russia. In addition, the increasing R&D expenditure (as % of GDP) of major countries of Europe is also contributing to the growth of autosampler vials market.

Autosampler vials market size image

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Market Segmentation

Our-in depth analysis of the global autosampler vials market includes the following segments:

By Product

The market is segmented by product type into crimp top, screw thread, snap ring, shell and others. Out of these, screw thread segment occupies the largest market of autosampler vials across the globe and is expected to achieve Y-o-Y growth rate of 7.64% in 2027 as compared to previous year. This demand is primarily driven by relatively lower cost and ease in sample handling in comparison to other products.

By Capacity

This segment is further categorized into five segments that include less than 1ml, 1.1-1.5ml, 1.6-2.0ml, 2.1-2.5ml & more than 3ml, out of which, 1.6-2.0 ml segment is capturing the largest share by value and by volume owing to its feasibility and ease of use and is considered to be most popularly used in end-use industries.

By Application

On the basis of application, the market is segmented into High Performance Liquid Chromatography (HPLC), Gas Chromatography and Others. The Gas Chromatography segment is anticipated to grow at the highest CAGR over the forecast period. However, HPLC is anticipated to be the most attractive segment in overall autosampler vials market owing to relatively higher utilization of HPLC as compared to other methods of chromatography.

By End-Use Industries

The end-use industries segment is further sub-divided into pharmaceutical and bio-pharmaceutical companies, food and beverages industry, oil and gas industry, environmental testing and other end use industries. Out of these, the pharmaceutical and bio-pharmaceutical companies segment is anticipated to grow by 45 BPS by value & by 65 BPS by volume between 2018 and 2027. This can be attributed to rising investment in the pharmaceutical sector by various private and government agencies to develop various advanced end products.

Autosampler vials market size image
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating The Market

    Some of the major industry leaders that are operating in the autosampler vials market include Avantor Inc., Borosil, Jasco, PerkinElmer Inc., Gilson Inc., Restek Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Merck Group and Thermo Fischer Scientific.

    VWR International, a company operating in the life science and healthcare equipment and solutions, was acquired by Avantor in 2017. VWR’s expansive channel access and deep customer relationships has strengthened Avantor’s abilities, adding a vital new dimension to the full scope of solutions.

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample